Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Abstract CT127: Phase I adoptive cellular therapy trial with actively personalized, multi-targeted CD8+ T-cells in patients with relapsed and/or refractory solid cancers (ACTologIMA101-101)

Cancer Res (2018) 78 (13_Supplement): CT127.

https://doi.org/10.1158/1538-7445.AM2018-CT127

Published: 01 July 2018

View article titled, Abstract CT127: Phase I adoptive cellular therapy trial with actively personalized, multi-targeted CD8+ T-cells in patients with relapsed and/or refractory solid cancers (ACTologIMA101-101)

Journal Articles

Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides

Jens Fritsche, Arun Satelli, Helen Hörzer, Barbara Rakitsch, Franziska Hoffgaard, Norbert Hilf, Oliver Schoor, Harpreet Singh-Jasuja, Weinschenk Toni

Cancer Res (2018) 78 (13_Supplement): 662.

https://doi.org/10.1158/1538-7445.AM2018-662

Published: 01 July 2018

View article titled, Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides

Journal Articles

Abstract 2789: Development of highly potent T-cell receptor bispecifics with picomolar activity against tumor-specific HLA ligands

Sebastian Bunk, Martin Hofmann, Felix Unverdorben, Leonie Alten, Meike Hutt, Claudia Wagner, Oliver Schoor, Mathias Ferber, Jens Fritsche, Toni Weinschenk, Harpreet Singh-Jasuja, Dominik Maurer, Carsten Reinhardt

Cancer Res (2018) 78 (13_Supplement): 2789.

https://doi.org/10.1158/1538-7445.AM2018-2789

Published: 01 July 2018

View article titled, Abstract 2789: Development of highly potent T-cell receptor bispecifics with picomolar activity against tumor-specific HLA ligands

Journal Articles

Abstract 3753: Identification of antibodies against a novel tumor-associated MHC/peptide-target and generation of highly specific and potent HLA-A*02^MMP1-003/CD3 TandAbs

Toni Weinschenk, Erich Rajkovic, Uwe Reusch, Michael Weichel, Kristina Ellwanger, Ivica Fucek, Michael Tesar, Dominik Hinz, Vera Molkenthin, Sebastian Bunk, Norbert Hilf, Oliver Schoor, Dominik Maurer, Kerstin Mock, Carsten Reinhardt, Martin Treder

Cancer Res (2017) 77 (13_Supplement): 3753.

https://doi.org/10.1158/1538-7445.AM2017-3753

Published: 01 July 2017

View article titled, Abstract 3753: Identification of antibodies against a novel tumor-associated MHC/peptide-target and generation of highly specific and potent HLA-A*02<sup>MMP1-003</sup>/CD3 TandAbs

Journal Articles

Abstract 2291: On- and off target toxicity profiling for adoptive cell therapy by mass spectrometry-based immunopeptidome analysis of primary human normal tissues

Oliver Schoor, Jens Fritsche, Sarah Kutscher, Andrea Mahr, Lea Stevermann, Annika Sonntag, Franziska Hoffgaard, Dominik Vahrenhorst, Julia Leibold, Valentina Goldfinger, Leonie Alten, Sebastian Bunk, Dominik Maurer, Steffen Walter, Hans-Georg Rammensee, Harpreet Singh-Jasuja, Toni Weinschenk

Cancer Res (2016) 76 (14_Supplement): 2291.

https://doi.org/10.1158/1538-7445.AM2016-2291

Published: 15 July 2016

View article titled, Abstract 2291: On- and off target toxicity profiling for adoptive cell therapy by mass spectrometry-based immunopeptidome analysis of primary human normal tissues

Journal Articles

Abstract SY27-03: Biomarker-guided development of novel multi-peptide cancer vaccines - from discovery to phase lll trials.

Harpreet Singh-Jasuja, Steffen Walter, Toni Weinschenk, Alexandra Kirner, Andrea Mayer-Mokler, Norbert Hilf, Oliver Schoor, Pierre-Yves Dietrich, James Richtie, Roy Rampling, Frank Mayer, Arnulf Stenzl, Brian Rini, Carsten Reinhardt, Hans-Georg Rammensee

Cancer Res (2013) 73 (8_Supplement): SY27-03.

https://doi.org/10.1158/1538-7445.AM2013-SY27-03

Published: 15 April 2013

View article titled, Abstract SY27-03: Biomarker-guided development of novel multi-peptide cancer vaccines - from discovery to phase lll trials.

Journal Articles

Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide

Cancer Res (2012) 72 (8_Supplement): 5365.

https://doi.org/10.1158/1538-7445.AM2012-5365

Published: 15 April 2012

View article titled, Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide

Journal Articles

Abstract 4773: Quantitative HLA-peptidomics by XPRESIDENT - differential quantitation of naturally processed HLA-restricted peptides for cancer immunotherapy development

Toni Weinschenk, Jens Fritsche, Oliver Schoor, Norbert Hilf, Andreas Weinzierl, Markus Templin, Thomas Knorpp, Harpreet Singh

Cancer Res (2010) 70 (8_Supplement): 4773.

https://doi.org/10.1158/1538-7445.AM10-4773

Published: 15 April 2010

View article titled, Abstract 4773: Quantitative HLA-peptidomics by XPRESIDENT - differential quantitation of naturally processed HLA-restricted peptides for cancer immunotherapy development

Journal Articles

Abstract 5623: Synergy of the immunomodulators GM-CSF and imiquimod for peptide-based therapeutic vaccines

Norbert Hilf, Nina Pawlowski, Sylvia Flohr, Oliver Schoor, Toni Weinschenk, Harpreet Singh

Cancer Res (2010) 70 (8_Supplement): 5623.

https://doi.org/10.1158/1538-7445.AM10-5623

Published: 15 April 2010

View article titled, Abstract 5623: Synergy of the immunomodulators GM-CSF and imiquimod for peptide-based therapeutic vaccines

Journal Articles

Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

Oliver Schoor, Norbert Hilf, Valérie Dutoit, Toni Weinschenk, Steffen Walter, Peter Lewandrowski, Sylvia Flohr, Claudia Trautwein, Cécile Gouttefangeas, Stefan Stevanović, Hans-Georg Rammensee, Philipp Beckhove, Christel Herold-Mende, Pierre-Yves Dietrich, Harpreet Singh

Cancer Res (2010) 70 (8_Supplement): 2396.

https://doi.org/10.1158/1538-7445.AM10-2396

Published: 15 April 2010

View article titled, Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

Journal Articles

A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays

Andreas O. Weinzierl, Dominik Maurer, Florian Altenberend, Nicole Schneiderhan-Marra, Karin Klingel, Oliver Schoor, Dorothee Wernet, Thomas Joos, Hans-Georg Rammensee, Stefan Stevanović

Cancer Res (2008) 68 (7): 2447–2454.

https://doi.org/10.1158/0008-5472.CAN-07-2540

Published: 01 April 2008

View article titled, A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays

Includes: Supplementary data

Journal Articles

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Susanne M. Schmidt, Kerstin Schag, Martin R. Müller, Toni Weinschenk, Silke Appel, Oliver Schoor, Markus M. Weck, Frank Grünebach, Lothar Kanz, Stefan Stevanovic, Hans-Georg Rammensee, Peter Brossart

Cancer Res (2004) 64 (3): 1164–1170.

https://doi.org/10.1158/0008-5472.CAN-03-2538

Published: 10 February 2004

View article titled, Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Journal Articles

Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines

Toni Weinschenk, Cécile Gouttefangeas, Markus Schirle, Florian Obermayr, Steffen Walter, Oliver Schoor, Raffael Kurek, Wolfgang Loeser, Karl-Horst Bichler, Dorothee Wernet, Stefan Stevanović, Hans-Georg Rammensee

Cancer Res (2002) 62 (20): 5818–5827.

Published: 15 October 2002

View article titled, Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines

NARROW

Abstract CT127: Phase I adoptive cellular therapy trial with actively personalized, multi-targeted CD8+ T-cells in patients with relapsed and/or refractory solid cancers (ACTologIMA101-101)

Abstract 662: IMA_Detect: Mass spectrometry guided development and clinical application of a companion diagnostic for adoptive cellular therapy against tumor associated HLA peptides

Abstract 2789: Development of highly potent T-cell receptor bispecifics with picomolar activity against tumor-specific HLA ligands

Abstract 3753: Identification of antibodies against a novel tumor-associated MHC/peptide-target and generation of highly specific and potent HLA-A*02^MMP1-003/CD3 TandAbs

Abstract 2291: On- and off target toxicity profiling for adoptive cell therapy by mass spectrometry-based immunopeptidome analysis of primary human normal tissues

Abstract SY27-03: Biomarker-guided development of novel multi-peptide cancer vaccines - from discovery to phase lll trials.

Abstract 5365: Prolonged survival of patients with advanced renal cancer responding to multi-peptide vaccine IMA901 after single-dose cyclophosphamide

Abstract 4773: Quantitative HLA-peptidomics by XPRESIDENT - differential quantitation of naturally processed HLA-restricted peptides for cancer immunotherapy development

Abstract 5623: Synergy of the immunomodulators GM-CSF and imiquimod for peptide-based therapeutic vaccines

Abstract 2396: IMA950: A novel multi-peptide cancer vaccine for treatment of glioblastoma

A Cryptic Vascular Endothelial Growth Factor T-Cell Epitope: Identification and Characterization by Mass Spectrometry and T-Cell Assays

Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only